Biotech

All Articles

Biogen's chief executive officer claimed no high-risk sell 2023. He's ready to become bold

.While Biogen's pharma peers are actually looking for late-stage properties with little risk, chief ...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has been actually a biotech looking for a pipeline after it scrapped its lead possession...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's condition program to Denali Therapi...

Takeda taps brand new mind people oncology service-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings and ...

Vertex, hammered through AATD once more, loses 2 properties on throw out pile

.Vertex's try to address an unusual genetic condition has struck another setback. The biotech tossed...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter incomes document had not been short of big information. The comp...

Galapagos stops briefly CAR-T cell treatment litigation over Parkinsonism case

.Galapagos has actually stopped briefly enrollment in a trial of a BCMA-directed CAR-T tissue treatm...

James Wilson leaving Penn to introduce two new biotechs

.After greater than thirty years, genetics treatment innovator James Wilson M.D., Ph.D., is actually...

3 biotechs try to defeat the summer season heat energy by dropping team

.As biotechs seek to turn a fresh page in August, at the very least three companies have dropped tea...

venBio raises $528M for fifth life scientific researches VC fund

.Veteran venture capital agency venBio has lifted an additional half a billion bucks to buy biotechs...